William H. Cevallos

557 total citations
18 papers, 432 citations indexed

About

William H. Cevallos is a scholar working on Pharmacology, Pharmacology and Molecular Biology. According to data from OpenAlex, William H. Cevallos has authored 18 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 4 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in William H. Cevallos's work include Drug Transport and Resistance Mechanisms (3 papers), Pharmacology and Obesity Treatment (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). William H. Cevallos is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Pharmacology and Obesity Treatment (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). William H. Cevallos collaborates with scholars based in United States, Canada and Taiwan. William H. Cevallos's co-authors include J.F. Berry, Paul T. Martin, Steven Troy, Cathie Leister, Richard M. Mangano, Irwin Lucki, Patricia Furlan, Mona Darwish, James F. Berry and Joan Korth‐Bradley and has published in prestigious journals such as Journal of Neurochemistry, Critical Care Medicine and Clinical Pharmacology & Therapeutics.

In The Last Decade

William H. Cevallos

17 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William H. Cevallos United States 10 130 129 90 54 53 18 432
Rika Aizawa Japan 11 237 1.8× 200 1.6× 88 1.0× 34 0.6× 174 3.3× 13 569
S. I. Ankier United Kingdom 15 70 0.5× 93 0.7× 130 1.4× 133 2.5× 24 0.5× 56 661
Fuchun Wang China 11 61 0.5× 35 0.3× 198 2.2× 95 1.8× 15 0.3× 73 649
V. Nimet İzgüt‐Uysal Türkiye 15 49 0.4× 31 0.2× 92 1.0× 61 1.1× 55 1.0× 42 541
Eric Legangneux Switzerland 14 163 1.3× 118 0.9× 179 2.0× 55 1.0× 71 1.3× 29 581
K. Schaffler United States 12 68 0.5× 29 0.2× 74 0.8× 167 3.1× 18 0.3× 51 415
Sara Pascoe-González Mexico 9 42 0.3× 72 0.6× 65 0.7× 82 1.5× 56 1.1× 20 358
Sang Kwan Moon South Korea 12 64 0.5× 54 0.4× 84 0.9× 55 1.0× 6 0.1× 16 428
Christian von Hehn United States 10 44 0.3× 32 0.2× 98 1.1× 219 4.1× 26 0.5× 21 509
B. Lemmer Germany 10 28 0.2× 30 0.2× 61 0.7× 170 3.1× 181 3.4× 21 435

Countries citing papers authored by William H. Cevallos

Since Specialization
Citations

This map shows the geographic impact of William H. Cevallos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Cevallos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Cevallos more than expected).

Fields of papers citing papers by William H. Cevallos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Cevallos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Cevallos. The network helps show where William H. Cevallos may publish in the future.

Co-authorship network of co-authors of William H. Cevallos

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Cevallos. A scholar is included among the top collaborators of William H. Cevallos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Cevallos. William H. Cevallos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Troy, Steven, Irwin Lucki, William H. Cevallos, et al.. (2000). Comparison of the Effects of Zaleplon, Zolpidem, and Triazolam on Memory, Learning, and Psychomotor Performance. Journal of Clinical Psychopharmacology. 20(3). 328–337. 79 indexed citations
2.
Darwish, Mona, Patrick Martin, William H. Cevallos, et al.. (1999). Rapid Disappearance of Zaleplon from Breast Milk after Oral Administration to Lactating Women. The Journal of Clinical Pharmacology. 39(7). 670–674. 17 indexed citations
3.
Greenblatt, David J., Jerold S. Harmatz, Lisa L. von Moltke, et al.. (1998). Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo*. Clinical Pharmacology & Therapeutics. 64(5). 553–561. 96 indexed citations
4.
Cevallos, William H., et al.. (1997). Evaluation of Pharmacokinetic Interaction Between Bromfenac and Phenytoin in Healthy Males. The Journal of Clinical Pharmacology. 37(2). 160–168. 4 indexed citations
5.
Boni, Joseph, et al.. (1997). Effects of Age and Gender on the Pharmacokinetics of Bromfenac in Healthy Volunteers. Annals of Pharmacotherapy. 31(4). 400–405. 5 indexed citations
6.
Ermer, James, Joseph Boni, William H. Cevallos, et al.. (1997). Bromfenac disposition in patients with impaired kidney function*. Clinical Pharmacology & Therapeutics. 61(3). 312–318. 5 indexed citations
7.
Boni, Joseph, et al.. (1997). The Influence of Bromfenac on the Pharmacokinetics and Pharmacodynamic Responses to Glyburide in Diabetic Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(4). 783–790. 4 indexed citations
8.
Cevallos, William H., et al.. (1997). Absolute Bioavailability of Bromfenac in Humans. Annals of Pharmacotherapy. 31(4). 395–399. 6 indexed citations
9.
Cevallos, William H., et al.. (1996). Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.. PubMed. 23(6). 984–9. 11 indexed citations
10.
Troy, Steven, et al.. (1991). The Absolute Bioavailability and Dose Proportionality of Intravenous and Oral Dosage Regimens of Recainam. The Journal of Clinical Pharmacology. 31(5). 433–439.
11.
Reichard, Georg, Horace MacVaugh, John R. Kues, et al.. (1985). Effect of phentolamine in controlling temperature and acidosis associated with cardiopulmonary bypass. Critical Care Medicine. 13(2). 72–76. 14 indexed citations
12.
Capuzzi, David M. & William H. Cevallos. (1984). Inhibition of Hepatic Cholesterol and Triglyceride Synthesis by Guanabenz Acetate. Journal of Cardiovascular Pharmacology. 6. S847–852. 7 indexed citations
13.
Cevallos, William H., William L. Holmes, Richard N. Myers, & Robert D. Smink. (1979). Swine in atherosclerosis research. Atherosclerosis. 34(3). 303–317. 12 indexed citations
14.
Cevallos, William H., et al.. (1968). Platelet Adhesiveness and Thrombosis in Rabbits on an Atherogenic Diet. Pharmacology. 18(2). 121–128. 8 indexed citations
15.
Turner, David A. & William H. Cevallos. (1968). Vitamin B12 and the lipids of the central nervous system. Clinical Biochemistry. 2. 1–11. 10 indexed citations
16.
Berry, James F. & William H. Cevallos. (1966). LIPID CLASS AND FATTY ACID COMPOSITION OF PERIPHERAL NERVE FROM NORMAL AND ORGANOPHOSPHORUS‐POISONED CHICKENS*. Journal of Neurochemistry. 13(2). 117–124. 19 indexed citations
17.
Berry, J.F., et al.. (1965). Lipid class and fatty acid composition of intact peripheral nerve and during wallerian degeneration. Journal of the American Oil Chemists Society. 42(6). 492–500. 125 indexed citations
18.
Lilly, Daniel M. & William H. Cevallos. (1956). II. CHEMICAL SUPPLEMENTS PROMOTING GROWTH IN CARNIVOROUS CILIATES*. Transactions of the New York Academy of Sciences. 18(6 Series II). 531–539. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rika Aizawa Breakdown of academic impact, for papers by S. I. Ankier Breakdown of academic impact, for papers by Fuchun Wang Breakdown of academic impact, for papers by V. Nimet İzgüt‐Uysal Breakdown of academic impact, for papers by Eric Legangneux Breakdown of academic impact, for papers by K. Schaffler Breakdown of academic impact, for papers by Sara Pascoe-González Breakdown of academic impact, for papers by Sang Kwan Moon Breakdown of academic impact, for papers by Christian von Hehn Breakdown of academic impact, for papers by B. Lemmer
Rankless by CCL
2026